TECX Q4 2019 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$634M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$245,000

Operating Income

-$23M

Net Income

-$23M

EPS (Diluted)

$-8.60

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$201M

Total Liabilities

$15M

Stockholders' Equity

$186M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$245,000	-$184,000	-33.2%
Operating Income	-$23M	-$17M	-40.5%
Net Income	-$23M	-$16M	-41.5%